Lawsuit raises liver safety questions about MASH drug Rezdiffra
Madrigal Pharmaceuticals’ former head of clinical development sued the company Oct. 9, alleging he was forced out after raising concerns about liver injury data and efficacy results for its MASH drug Rezdiffra, according to a complaint filed in the U.S. District Court for the Northern District of Illinois. Madrigal disputes the allegations. Michael Charlton, MD, […] The post Lawsuit raises liver safety questions about MASH drug Rezdiffra appeared first on Becker's Hospital Review | He...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.